Search research articles
Contact Us
Filters
Showing results (21-30 of 169) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
July 6, 2014
Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup
Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.
Pathology Oncology Research : POR
|
August 30, 2008
Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy
Nicolas Josselin, Hélène Libouban, Mamoun Dib, et al.
Cancer Chemotherapy and Pharmacology
|
May 26, 2004
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design
David Khayat, Olivier Rixe, René Brunet, et al.
Plos One
|
February 15, 2013
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ
Etienne D Foucher, Simon Blanchard, Laurence Preisser, et al.
Clinical Breast Cancer
|
January 21, 2022
Care pathway of women with interval breast cancer in 2016, based on medico-administrative data
Camille Bertrand, Christine Le Bihan-Benjamin, Florence Molinié, et al.
Cancer Medicine
|
June 8, 2019
Breast cancer screening: Impact on care pathways
Delphine Lefeuvre, Nathalie Catajar, Christine Le Bihan Benjamin, et al.
Stroke
|
December 27, 2011
Arterial stiffness and stroke in sickle cell disease
Cristina Belizna, Laurent Loufrani, Alaa Ghali, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
May 29, 2004
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
Thomas Prébet, Sophie Ducastelle, Stephan Debotton, et al.
Blood
|
September 20, 2007
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Jerome Tamburini, Nicolas Chapuis, Valérie Bardet, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 169) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
July 6, 2014
Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup
Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.
Pathology Oncology Research : POR
|
August 30, 2008
Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy
Nicolas Josselin, Hélène Libouban, Mamoun Dib, et al.
Cancer Chemotherapy and Pharmacology
|
May 26, 2004
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design
David Khayat, Olivier Rixe, René Brunet, et al.
Plos One
|
February 15, 2013
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγ
Etienne D Foucher, Simon Blanchard, Laurence Preisser, et al.
Clinical Breast Cancer
|
January 21, 2022
Care pathway of women with interval breast cancer in 2016, based on medico-administrative data
Camille Bertrand, Christine Le Bihan-Benjamin, Florence Molinié, et al.
Cancer Medicine
|
June 8, 2019
Breast cancer screening: Impact on care pathways
Delphine Lefeuvre, Nathalie Catajar, Christine Le Bihan Benjamin, et al.
Stroke
|
December 27, 2011
Arterial stiffness and stroke in sickle cell disease
Cristina Belizna, Laurent Loufrani, Alaa Ghali, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
May 29, 2004
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
Thomas Prébet, Sophie Ducastelle, Stephan Debotton, et al.
Blood
|
September 20, 2007
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Jerome Tamburini, Nicolas Chapuis, Valérie Bardet, et al.
Page
of 17